Fluxá Daniela, Segovia Jorge, Florenzano Matías, Salinas Jessica, Flores Lilian, Simian Daniela, Quera Rodrigo
Departamento de Gastroenterología, Clínica Las Condes, Santiago, Chile.
Unidad de Infectología, Departamento de Medicina Interna, Clínica Las Condes, Santiago, Chile.
Rev Chilena Infectol. 2017 Oct;34(5):518-519. doi: 10.4067/S0716-10182017000500518.
There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn's disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.
目前尚无关于炎症性肠病患者预防耶氏肺孢子菌肺炎的循证指南。我们报告了1例接受英夫利昔单抗和甲氨蝶呤治疗的克罗恩病患者发生耶氏肺孢子菌肺炎的病例。该病例强调了在接受生物治疗的炎症性肠病患者中考虑这种感染可能性的重要性。
